File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A Heart‐Breast Cancer‐on‐a‐Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by Cancer Chemotherapy

TitleA Heart‐Breast Cancer‐on‐a‐Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by Cancer Chemotherapy
Authors
Keywordsbreast cancer
cardiotoxicity
electrochemical biosensors
iPSC-cardiac tissues
organs-on-a-chip
Issue Date2021
PublisherWiley - VCH Verlag GmbH & Co KGaA. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jabout/107640323/2421_info.html
Citation
Small, 2021, v. 17 n. 15, p. article no. 2004258 How to Cite?
AbstractCardiotoxicity is one of the most serious side effects of cancer chemotherapy. Current approaches to monitoring of chemotherapy-induced cardiotoxicity (CIC) as well as model systems that develop in vivo or in vitro CIC platforms fail to notice early signs of CIC. Moreover, breast cancer (BC) patients with preexisting cardiac dysfunctions may lead to different incident levels of CIC. Here, a model is presented for investigating CIC where not only induced pluripotent stem cell (iPSC)-derived cardiac tissues are interacted with BC tissues on a dual-organ platform, but electrochemical immuno-aptasensors can also monitor cell-secreted multiple biomarkers. Fibrotic stages of iPSC-derived cardiac tissues are promoted with a supplement of transforming growth factor-β 1 to assess the differential functionality in healthy and fibrotic cardiac tissues after treatment with doxorubicin (DOX). The production trend of biomarkers evaluated by using the immuno-aptasensors well-matches the outcomes from conventional enzyme-linked immunosorbent assay, demonstrating the accuracy of the authors’ sensing platform with much higher sensitivity and lower detection limits for early monitoring of CIC and BC progression. Furthermore, the versatility of this platform is demonstrated by applying a nanoparticle-based DOX-delivery system. The proposed platform would potentially help allow early detection and prediction of CIC in individual patients in the future.
Persistent Identifierhttp://hdl.handle.net/10722/302361
ISSN
2023 Impact Factor: 13.0
2023 SCImago Journal Rankings: 3.348
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLee, J-
dc.contributor.authorMehrotra, S-
dc.contributor.authorZare-Eelanjegh, E-
dc.contributor.authorRodrigues, RO-
dc.contributor.authorAkbarinejad, A-
dc.contributor.authorGe, D-
dc.contributor.authorAmato, L-
dc.contributor.authorKiaee, K-
dc.contributor.authorFang, Y-
dc.contributor.authorRosenkranz, A-
dc.contributor.authorKeung, W-
dc.contributor.authorMandal, BB-
dc.contributor.authorLi, RA-
dc.contributor.authorZhang, T-
dc.contributor.authorLee, H-
dc.contributor.authorDokmeci, MR-
dc.contributor.authorZhang, YS-
dc.contributor.authorKhademhosseini, A-
dc.contributor.authorShin, SR-
dc.date.accessioned2021-09-06T03:31:11Z-
dc.date.available2021-09-06T03:31:11Z-
dc.date.issued2021-
dc.identifier.citationSmall, 2021, v. 17 n. 15, p. article no. 2004258-
dc.identifier.issn1613-6810-
dc.identifier.urihttp://hdl.handle.net/10722/302361-
dc.description.abstractCardiotoxicity is one of the most serious side effects of cancer chemotherapy. Current approaches to monitoring of chemotherapy-induced cardiotoxicity (CIC) as well as model systems that develop in vivo or in vitro CIC platforms fail to notice early signs of CIC. Moreover, breast cancer (BC) patients with preexisting cardiac dysfunctions may lead to different incident levels of CIC. Here, a model is presented for investigating CIC where not only induced pluripotent stem cell (iPSC)-derived cardiac tissues are interacted with BC tissues on a dual-organ platform, but electrochemical immuno-aptasensors can also monitor cell-secreted multiple biomarkers. Fibrotic stages of iPSC-derived cardiac tissues are promoted with a supplement of transforming growth factor-β 1 to assess the differential functionality in healthy and fibrotic cardiac tissues after treatment with doxorubicin (DOX). The production trend of biomarkers evaluated by using the immuno-aptasensors well-matches the outcomes from conventional enzyme-linked immunosorbent assay, demonstrating the accuracy of the authors’ sensing platform with much higher sensitivity and lower detection limits for early monitoring of CIC and BC progression. Furthermore, the versatility of this platform is demonstrated by applying a nanoparticle-based DOX-delivery system. The proposed platform would potentially help allow early detection and prediction of CIC in individual patients in the future.-
dc.languageeng-
dc.publisherWiley - VCH Verlag GmbH & Co KGaA. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jabout/107640323/2421_info.html-
dc.relation.ispartofSmall-
dc.rightsSubmitted (preprint) Version This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Accepted (peer-reviewed) Version This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.subjectbreast cancer-
dc.subjectcardiotoxicity-
dc.subjectelectrochemical biosensors-
dc.subjectiPSC-cardiac tissues-
dc.subjectorgans-on-a-chip-
dc.titleA Heart‐Breast Cancer‐on‐a‐Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by Cancer Chemotherapy-
dc.typeArticle-
dc.identifier.emailKeung, W: wkeung@hku.hk-
dc.identifier.emailLi, RA: ronaldli@hkucc.hku.hk-
dc.identifier.authorityKeung, W=rp01887-
dc.identifier.authorityLi, RA=rp01352-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/smll.202004258-
dc.identifier.pmid33094918-
dc.identifier.pmcidPMC8049959-
dc.identifier.scopuseid_2-s2.0-85093526727-
dc.identifier.hkuros324840-
dc.identifier.volume17-
dc.identifier.issue15-
dc.identifier.spagearticle no. 2004258-
dc.identifier.epagearticle no. 2004258-
dc.identifier.isiWOS:000581066800001-
dc.publisher.placeGermany-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats